Bausch + Lomb introduced micro incision cataract surgery (MICS) to the market with its 1.8 mm MICS Phacoemulsification (cataract removal using ultrasound). The advent of MICS Phaco means that surgeons can benefit from Bausch + Lomb's clinical combination: phacoemulsification through a 1.8 mm incision and IOL technology, including a range of Standard IOLs such as the enVista monofocal, the Akreos MICS and AO lenses, and Specialty IOLs such as the Crystalens accommodating and enVista Toric lenses, that can be implanted through an enlarged incision.
Introducing the new standard in acrylic IOL performance that has no glistenings detected at any time in a 2-year prospective study with Bausch + Lomb aspheric Advanced Optics. It can be inserted through a 2.2mm incision and is designed to minimise PCO.
enVista Toric is the new Glistening-free, hydrophobic acrylic IOL from Bausch + Lomb which corrects regular astigmatism. Its unique haptics are designed to secure a predictable astigmatism correction.
The Akreos Micro Incision Lens (MIL) combines the benefits of an aberration-free aspheric acrylic lens with the material and design characteristics that allow it to be inserted into a true 1.8 mm incision.
Bausch + Lomb's Akreos Adapt AO lens is the world's first aspheric acrylic IOL with aberration neutrality, because the aberrations present in the eye differ from person to person.
Crystalens AO Lens is an artificial lens implant that can treat both a person's cataracts and presbyopia —the clouding or hardening of your lenses, and the loss of near and intermediate vision, respectively.